GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients

(MedPage Today) — GLP-1 receptor agonists were linked to a lower risk of developing epilepsy in adults with type 2 diabetes, a large US study showed. Compared with DPP-4 inhibitors, the use of GLP-1 receptor agonists was associated with a 16% lower risk…